BDMD — Baird Medical Investment Holdings Income Statement
0.000.00%
Last trade - 00:00- $229.91m
- $231.10m
Annual income statement for Baird Medical Investment Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | — | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Total Operating Expenses | — | 0.707 | 2.04 | 7.24 |
| Operating Profit | 0 | -0.707 | -2.04 | -7.24 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | — | -0.697 | 1.24 | -2.3 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | — | -0.697 | 0.623 | -3.29 |
| Net Income Before Extraordinary Items | ||||
| Net Income | — | -0.697 | 0.623 | -3.29 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | 0 | -0.697 | 0.623 | -3.29 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | — | -0.024 | 0.022 | -0.349 |
| Dividends per Share |